Group name
RPP
BCR
156 (24.7)
Continence
496/578 (85.8)
remark
Continence rate
Survival outcome
21 (3.0)
remark
Death from prostate cancer, No. (%)
Survival outcome
21 (3.0)
remark
Death from prostate cancer, No. (%)
Other Outcomes
35 (5.1)
remark
Distant metastasis, No. (%)
Follow Up Time
at 1 yr